Know what's due
See upcoming items, completed entries and paused routines from a simple daily view.
AEVLI brings schedules, supplies, logs and progress into one calm place — without turning your routine into noise.
Review what you logged without digging through notes or reminders.
AEVLI is designed around the practical things people need to organise consistently.
See upcoming items, completed entries and paused routines from a simple daily view.
Record routine entries, weight, symptoms, measurements, wellness and hydration without friction.
Track remaining supply and understand when something is running low.
Keep a useful history you can review yourself or deliberately share as a summary.
Independent educational guides, brand pages and comparisons sit alongside the app — clearly separated from personal tracking.
Clear guides for organising GLP-1 routines, schedules, supplies and progress.
Explore GLP-1Educational reference pages for peptide routines and personal tracking.
Explore PeptidesEvidence-aware profiles for experimental and investigational peptides, clearly separated from approved medicines.
Explore Research peptidesTrack routines, bloodwork and administration schedules in one place.
Explore TRT & HRTPreparation, subcutaneous self-injection and sharps aftercare for prescribed medicines after hands-on training.
Explore Injection safetyOrganise supplement routines and learn how products compare.
Explore SupplementsA clear, evidence-aware introduction to semaglutide, its role in GLP-1 treatment and the practical things people often track alongside a prescribed routine.
Read the semaglutide guide →The newest AEVLI articles are surfaced directly from the homepage so readers do not have to hunt through the library.
Three clear guides for prescribed self-injection after hands-on training, including preparation, subcutaneous technique boundaries and sharps disposal.
Read article →Evidence profile · Approved peptide medicineWhat the GHRH analogue is approved for, what randomized human studies show and where the evidence should not be extrapolated.
Read article →Evidence profile · Investigational medicineA clear look at the triple GIP, GLP-1 and glucagon receptor agonist, its clinical-development evidence and current regulatory status.
Read article →Evidence profile · Research peptideSeparate the extensive preclinical discussion from the much thinner human evidence and current regulatory context.
Read article →Comparison guide · ComparisonCompare what is actually known about these two popular research compounds without treating animal data as proven human benefit.
Read article →Comparison guide · GLP-1 & metabolicCompare receptor targets, approval status and the maturity of the human evidence across three widely discussed medicines or candidates.
Read article →Practical guide · Evidence guideUnderstand what purity percentages, analytical methods and certificates can tell you—and what they cannot prove.
Read article →Private tracking data stays separate from commercial offer selection.
AEVLI is a tracking and organisation tool, not a prescribing service.
Affiliate-supported content will be clearly disclosed.
The core tracker will be free. Store links will appear here only after the official releases are approved.